The global d-mannose market size was valued at USD 1.12 billion in 2021 and is poised to grow at a significant CAGR of 3.6% during the forecast period 2022-28. The demand for D-glucose as a natural alternative to antibiotics for the treatment of urinary tract infections is driving the market forward. Because of the population's weakened immune system and inadequate resistance against microorganisms, the prevalence of urinary infections is rising, boosting market growth.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/d-mannose-market/  

D-Mannose monosaccharide is a sugar monomer from the aldohexose family of carbohydrates that is required for glycosylation of specific proteins in human metabolism. D-Mannose is water soluble and ethanol soluble to a lesser extent. D-mannose and D-fructose are in significant demand in North America, followed by Europe, on a global scale. Due to growing awareness and acceptance of low-calorie foods and natural antibiotic alternatives, demand from these regions is likely to increase. The market for D-Mannose is rapidly approaching pre-COVID levels, with a robust growth rate projected over the forecast period, owing to the economic recovery in most emerging countries.  

The global d-mannose market segmentation:
1) By Product Type: Powder, Capsules, and Tablets.
2) By Application: Pharmaceuticals, Animal Feed, Dietary Supplement, and Others.

Due to the large quantity of d-mannose manufacturing in the region and the growing awareness of health and wellbeing, Asia-Pacific is expected to have the largest share of the D-mannose market. North America, on the other hand, is predicted to increase at a large rate from 2021 to 2028, owing to the rapid shift in consumer preferences toward healthy and low-calorie products.

Request sample report at  https://precisionbusinessinsights.com/request-sample?product_id=23041                                                  

Some of the major key players working in the D-Mannose Market, are E.I. du Pont de Nemours (U.S) Hanseler AG (Switzerland) Kyowa Hakko Kirin Co Ltd. (Japan) VWR Corporation (U.S) Nutraceutical International Corporation (U.S) Bio-Tech Pharmacal Inc. (U.S) Atrium Innovations Inc. (Canada)

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747